The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
Open Access
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 3 (2) , 91-94
- https://doi.org/10.1186/bcr277
Abstract
P27 is an inhibitor of cyclin dependent kinase involved in the regulation of the cell cycle. In this commentary we discuss the current knowledge on p27 in breast cancer and its significance in predicting the outcome. p27 protein levels are high in most cases of breast carcinomas, are correlated with the levels of cyclin D1 and estrogen receptor, and could be a useful predictor of survival, because they are low in aggressive carcinomas. Immunodetection of p27 in breast tumors could be useful in the assessment of prognosis, especially in those cases in which the commonly used parameters are insufficient, and might ultimately influence the therapy of this disease.Keywords
This publication has 30 references indexed in Scilit:
- The F-box protein familyGenome Biology, 2000
- SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27Nature Cell Biology, 1999
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27Current Biology, 1999
- The murine gene p27Kip1 is haplo-insufficient for tumour suppressionNature, 1998
- Translational Control of p27 Kip1 Accumulation During the Cell CycleScience, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.1995
- Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.1995
- p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.1995